Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mg2+-dependent Ca2+-activated ATPase of microsoma fraction from the grey matter of cerebral great hemispheres determined after the preliminary treatment of the preparation with 0.1% digitonin, while preserved in the medium with 10 mM mercaptoethanol for seven days at a temperature of 4-6 degrees C is inactivated by 10-15% and approximately by 50% while preserved without mercaptoethanol. Mercaptoethanol does not make reactivating effect. SH-reagents at definite concentrations completely inhibit the activity of Mg2+, Ca2+-ATPase. Half-maximum inhibition of the enzyme is reached with the salirgan, p-CMB and
NEM
concentrations of 5-10(-6) M, 5-10(-6) M and 5-10(-3) M, respectively.
Mg2+-ATPase
is not suppressed completely, and at high concentrations of SH-reagents the residual activity is 1.3 muM of Pi per 1 mg of protein in 1 hr. ATP in the concentrations optimal for manifestation of Mg2+, Ca2+-ATPase (3 mM) efficiently protects the enzyme from the inactivating effect of
NEM
. This gives reasons to suppose that the active centre of Mg2+, Ca2+-ATPase contains an SH-group. The quantity of SH-groups readily accessible of the Ellman reactive in the initial preparation of the brain microsomes is 45 + 2.0 nM per 1 mg of protein and in the preparation dissolved in 2.5% sodium dodecyl sulphate, 110 + 7.8 nmM per 1 mg of protein. In the presence of 0.1% digitonin the quantity of SH-groups of the preparation is 55 + 3.5 nM per 1 mg of protein, simultaneously such treatment of detergent results in manifestation of Mg2+, Ca2+-ATPase activity. An inactivating effect of SH-reagents and the protective effect of ATP indicate similarity of the enzyme under study to Mg2+, Ca2+-ATPase of sarcoplasmatic reticulum.
...
PMID:[SH-group and Mg2+-dependent Ca2+-activated ATPase activity of the microsome fraction of the brain]. 12 70
The effect of Sa modification with
NEM
, which activates
Mg2+-ATPase
through an enhancement of the association of actin and myosin, was investigated on the superprecipitation, clearing and Mg2+-ITPase of myosin B with reference to the effect of S1-blocking. 1. Superprecipitation induced by ATP was markedly enhanced by Sa-blocking even at high concentrations of Mg2+ and substrate; this may be due to an increase in the affinity of myosin and actin on blocking Sa. 2. Nevertheless, neither ITP-induced superprecipitation nor Mg2+-ITPase was affected by Sa modification. 3. Blocking of S1 brought about the inhibition of ATP- and ITP-induced superprecipitation and Mg2+-ITPase activity, suggesting that S1-blocking decreases the affinity of myosin and actin. 4. Sa-blocked myosin B showed greater resistance to clearing by ATP, especially in the presence of Ca2+ ions, whereas in the clearing response of actomyosin gel to PPi no difference between Sa-blocked and unmodified myosins B was observed. On the other hand, the clearing response of myosin B became more sensitive to both ATP and PPi on blocking S1. Based on the above results and preliminary data suggesting that Sa is located in LMM, the interaction of myosin filaments and actin filaments under physiological conditions is discussed.
...
PMID:The sulfhydryl groups involved in the active site of myosin B adenosinetriphosphatase. II. Effect of modification of the Sa thiol group on superprecipitation and clearing. 19 36
N-Ethylmaleimide
was employed as a surface label for sarcolemmal proteins after demonstrating that it does not penetrate to the intracellular space at concentrations below 1.10(-4) M. The sarcolemmal markers, ouabain-sensitive (Na+ +K+)-ATPase and Na+/Ca2+-exchange activities, were inhibited in N-ethylmaleimide perfused hearts. Intracellular activities such as creatine phosphokinase, glutamate-oxaloacetate transaminase and the internal phosphatase site of the Na+ pump (K+-p-nitrophosphatase) were not affected. Almost 20% of the (Ca2+ +Mg2+)-ATPase and Ca2+ pump were inhibited indicating the localization of a portion of this activity in the sarcolemma. Sarcolemma purified by a recent method (Morcos, N.C. and Drummond, G.I. (1980) Biochim. Biophys. Acta 598, 27-39) from N-ethylmaleimide-perfused hearts showed loss of approx. 85% of its (Ca2+ +Mg2+-ATPase and Ca2+ pump compared to control hearts. (Ca2+ +Mg2+)-ATPase and Ca2+ pump activities showed two classes of sensitivity to vanadate ion inhibition. The high vanadate affinity class (K1/2 for inhibition approx. 1.5 microM) may be localized in the sarcolemma and represented approx. 20% of the total inhibitable activity in agreement with estimates from N-ethylmaleimide studies. Sucrose density fractionation indicated that only a small portion of
Mg2+-ATPase
and Ca2+-ATPase may be associated with the sarcolemma. The major portion of these activities seems to be associated with high density particles.
...
PMID:Localization of (Ca2+ + Mg2+)-ATPase, Ca2+ pump and other ATPase activities in cardiac sarcolemma. 628 90